Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Delineating the transcriptional network of prognostic gene signatures refines treatment recommendations for lymph node negative breast cancer patients

ABSTRACT: To define proliferative and senescent cell transcriptional profiles, we performed genome-wide expression analyses of growing and senescent mouse embryonic fibroblasts (MEFs)

ORGANISM(S): Mus musculus

PROVIDER: GSE62369 | GEO | 2015/09/30

SECONDARY ACCESSION(S): PRJNA263928

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Delineating the Transcriptional Network of Prognostic Gene Signatures Refines Treatment Recommendations for Lymph Node-negative Breast Cancer Patients

Project description:We performed Chip-Seq analyses of several DNA binding transcription factors predicted to function as "master transcriptional regulators" (MTRs) of breast cancer prognostic gene signatures in primary human mammary epithelial cells (HMECs). These analyses demonstrated that these factors frequently co–bind the promoters of genes, the expression of which is associated with a proliferative phenotype and poor patient outcome. These data suggest that these predicted MTRs do indeed drive the expression of gene signatures associated with poor patient outcome in breast cancer.

2015-09-30 | GSE62425 | GEO

Prognostic value of gene signatures and proliferation in lymph node negative breast cancer

Project description: Not available

| S-ECPF-GEOD-46563 | biostudies-other

Prognostic value of gene signatures and proliferation in lymph-node-negative breast cancer.

Project description: Not available

| S-EPMC3944091 | biostudies-literature

Prognostic value of gene signatures and proliferation in lymph node negative breast cancer

Project description:Analyses whether, and if so, gene expression can add prognostic information in the subgroups of patients with tumours with low or high proliferative activity. As proliferation measured with MAI and PPH3 has repeatedly been shown to be the best prognosticator in node-negative breast cancer (high sensitivity, little overtreatment).

2014-03-05 | GSE46563 | GEO